CROWDER, TIMOTHY MORGAN,SCOTT, DAVID W.,TAYLOR, JOHN CLAYTON
申请号：
CA3046361
公开号：
CA3046361A1
申请日:
2017.12.12
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention relates to pharmaceutical formulations of non-naturally occurring peptides to bind to sodium channels and inhibit activation of the sodium channels. The invention further relates to methods for regulating of sodium absorption and fluid volume and treating disorders responsive to modulating sodium absorption by modulating the binding of specialized non-naturally occurring peptides to sodium channels.
